BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23674845)

  • 1. Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma.
    Giannitrapani L; Soresi M; Balasus D; Licata A; Montalto G
    World J Gastroenterol; 2013 Apr; 19(16):2449-55. PubMed ID: 23674845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC.
    Fabris C; Falleti E; Cussigh A; Bitetto D; Fontanini E; Bignulin S; Cmet S; Fornasiere E; Fumolo E; Fangazio S; Cerutti A; Minisini R; Pirisi M; Toniutto P
    J Hepatol; 2011 Apr; 54(4):716-22. PubMed ID: 21146242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional SNP of the Interleukin-18 gene is associated with the presence of hepatocellular carcinoma in hepatitis B virus-infected patients.
    Kim YS; Cheong JY; Cho SW; Lee KM; Hwang JC; Oh B; Kimm K; Lee JA; Park BL; Cheong HS; Shin HD; Kim JH
    Dig Dis Sci; 2009 Dec; 54(12):2722-8. PubMed ID: 19757044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PNPLA3 I148M polymorphism and progressive liver disease.
    Dongiovanni P; Donati B; Fares R; Lombardi R; Mancina RM; Romeo S; Valenti L
    World J Gastroenterol; 2013 Nov; 19(41):6969-78. PubMed ID: 24222941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis B virus and hepatitis C virus infection.
    Sghaier I; Zidi S; Mouelhi L; Ghazoueni E; Brochot E; Almawi WY; Loueslati BY
    Br J Biomed Sci; 2019 Jan; 76(1):35-41. PubMed ID: 30421643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
    Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
    Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL17A gene polymorphism, serum IL17 and total IgE in Egyptian population with chronic HCV and hepatocellular carcinoma.
    ELBassuoni MA; Abd El Fatah G; Zaghla H
    Immunol Lett; 2015 Dec; 168(2):240-5. PubMed ID: 26367076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common polymorphism in the NCAN gene is associated with hepatocellular carcinoma in alcoholic liver disease.
    Nischalke HD; Lutz P; Krämer B; Söhne J; Müller T; Rosendahl J; Fischer J; Berg T; Hittatiya K; Fischer HP; Soyka M; Semmo N; Nattermann J; Sauerbruch T; Strassburg CP; Stickel F; Spengler U
    J Hepatol; 2014 Nov; 61(5):1073-9. PubMed ID: 24946282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients.
    Sghaier I; Mouelhi L; Rabia NA; Alsaleh BR; Ghazoueni E; Almawi WY; Loueslati BY
    Cytokine; 2017 Jan; 89():62-67. PubMed ID: 28340949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
    de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V
    Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease.
    Schott E; Witt H; Pascu M; van Boemmel F; Weich V; Bergk A; Halangk J; Müller T; Puhl G; Wiedenmann B; Berg T
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):947-51. PubMed ID: 18049163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients.
    Talaat RM; Esmail AA; Elwakil R; Gurgis AA; Nasr MI
    Chin J Cancer; 2012 Jan; 31(1):29-35. PubMed ID: 22200181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent and additive interaction between tumor necrosis factor β +252 polymorphisms and chronic hepatitis B and C virus infection on risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Wu HF; Tsai MF; Tsai HR; Chuang LY; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Tsai JF
    Asian Pac J Cancer Prev; 2014; 15(23):10209-15. PubMed ID: 25556449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of IL-12 B Gene Polymorphism with Staging of Liver Disease in Chronic HCV Patients.
    Elwan N; Amr K; Elyamany S; Elkhalawany W; Soliman S; Ziada M; Abd-Elsalam S
    Infect Disord Drug Targets; 2018; 18(2):122-128. PubMed ID: 28595541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-1ß and interleukin-1 receptor accessory protein gene polymorphisms are associated with persistent hepatitis B virus infection.
    Kim SS; Cheong JY; Lee D; Lee SK; Kim MH; Kwack K; Yang SJ; Lee HY; Cho SW
    Hepatogastroenterology; 2012; 59(113):190-7. PubMed ID: 22251538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of IL-27p28 (rs153109) and TNF-α (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients.
    Tharwat E; Gad GFM; Nazmy MH; Mohamed HI; Hamza N; Wahid A; Ibrahim ARN
    Immunol Invest; 2019 Apr; 48(3):255-267. PubMed ID: 30204505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of transmembrane 6 superfamily member 2 rs58542926 polymorphism in chronic liver disease: A meta-analysis of 24,147 subjects.
    Chen X; Zhou P; De L; Li B; Su S
    Mol Genet Genomic Med; 2019 Aug; 7(8):e824. PubMed ID: 31309745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.